β¨ Medicines Distribution Consent
21 OCTOBER 2004
NEW ZEALAND GAZETTE, No. 134
3305
Dosage Form:
Powder for oral solution
New Zealand Sponsor:
Multichem NZ Limited
Manufacturer:
Cipla Limited, Kurkumbh Village, Taluka β Daund, District β Pune, Maharashtra State, India
Product:
Solox
Active Ingredient:
Lansoprazole 30mg
Dosage Form:
Capsule
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer:
Liconsa SA, Azuqueca de Henares, Guadalajara, Spain
Product:
Vistil
Active Ingredient:
Polyvinyl alcohol 1.4%w/v
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Tubilux Pharma SpA, Pomezia, Rome, Italy
Dated this 14th day of October 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go7020
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Actrapid Flexpen
Active Ingredient:
Neutral insulin, human, pyr 100IU/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited
Manufacturers:
Novo Nordisk A/S, Kalundborg, Denmark
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product:
Actrapid Innolet
Active Ingredient:
Neutral insulin, human, pyr 100IU/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited
Manufacturers:
Novo Nordisk A/S, Kalundborg, Denmark
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product:
Actrapid Novolet
Active Ingredient:
Neutral insulin, human, pyr 100IU/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited
Manufacturers:
Novo Nordisk A/S, Hillerod, Denmark
Novo Nordisk A/S, Kalundborg, Denmark
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product:
Actrapid Penfill
Active Ingredient:
Neutral insulin, human, pyr 100IU/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited
Manufacturers:
Novo Nordisk A/S, Hillerod, Denmark
Novo Nordisk A/S, Kalundborg, Denmark
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Novo Nordisk Pharmaceutical Industries, Inc., Clayton, North Carolina, United States of America
Novo Nordisk Pharmaceutique S.A., Chartres Cedex, France
Product:
Actrapid
Active Ingredient:
Neutral insulin, human, pyr 100IU/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited
Manufacturers:
Novo Nordisk A/S, Kalundborg, Denmark
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product:
Mixtard 30
Active Ingredients:
Isophane insulin, human, pyr 70IU/mL
Neutral insulin, human, pyr 30IU/mL
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2004, No 134
Gazette.govt.nz —
NZ Gazette 2004, No 134
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare14 October 2004
Medicines, Distribution, Health
- DON MATHESON, Deputy Director-General, Public Health
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social WelfareMedicines, Distribution, Health